http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Find Your BFF: Voting Opens Today for Sanrio's 40th Anniversary Character Ranking
-
AdPlayer.Pro SaaS Ad Tech Company Introduces Another Series of Product Upgrades
-
RICH PRODUCTS AND FUNFETTI® SWEETEN PARTNERSHIP WITH NEW CAKE OFFERING
-
Metrie® Expands Product Assortment, Adding Interior Doors to Key Markets in the Midwest and Florida
-
Belden to Announce First Quarter 2025 Results
-
VETS Indexes honors nearly 300 organizations in the 2025 VETS Indexes Employer Awards
-
Liberty Star Minerals Chairman Pete O’Heeron Engages with Congressional Leaders in D.C. to Champion U.S. Critical Mineral Independence
-
Appian Secures the Government's Most Sensitive Civilian Data with FedRAMP® High Authorization for Appian Government Cloud
-
Amongst Volatility in The Markets, More Organizations Embrace Bitcoin, Adding Cryptocurrency to Their Treasury
-
GUINNESS SPOTLIGHTS 'LOVELY DAYS' ACROSS THE COUNTRY IN NEW CAMPAIGN
-
Loacker Invites Fans to Unwrap 100 Years of "Pure (Italian) Goodness" in Limited-Edition Gift Box with Giada De Laurentiis
-
Boys & Girls Clubs of Metro Louisiana Receives Epic Experience from Northern Tool + Equipment
-
Over 53 Million Myeloma Milestones Shared During 2025 Myeloma Action Month
-
Biocon Biologics recieves FDA approval for Jobevne
-
Biocon Biologics Announces U.S. FDA Approval for Jobevne™, Biosimilar Bevacizumab, Expanding Its Oncology Portfolio
-
GivBux to Be Featured on VERB’s 'Go Fund Yourself' TV Show on Cheddar TV
-
GivBux to Be Featured on VERB’s 'Go Fund Yourself' TV Show on Cheddar TV
-
Foresight and Indian Drone Manufacturer Sign MOU for Autonomous Industrial Drones Project
-
Pluri (PLUR) Announces Two New Patents for 3D Expansion of Immune Cells in the United States and Israel
-
Versatility Of Commercial Drones Performing Growing Number of Tasks is Driving Rapidly Increasing Adoption Rate
-
Cellebrite to Report First-Quarter 2025 Financial Results on May 14, 2025
-
Pluri Announces Expansion of Intellectual Property Portfolio with Two Granted Patents for 3D Expansion of Immune Cells in the United States and Israel
-
Raadr, Doing Business as Telvantis, Transitions From Restructuring to Execution; Launches Phase 2 of Growth Plan
-
Fresh Ways to Frosty: Wendy's Reimagines Famous Dessert with April Launch of Frosty Swirls and May Launch of Frosty Fusions
-
Snow Lake Resources (LITM) Updates on the JV with Global Uranium and Enrichment Limited on the Pine Ridge Uranium Project
-
AtriCure (ATRC) Announces First Use of the AtriClip PRO-Mini Device
-
Soluna Holdings (SLNH) Issues March 2025 Business Update
-
Arcturus Therapeutics (ARCT) Receives U.S. FDA Fast Track Designation for the STARR® mRNA Vaccine Candidate ARCT-2304 for Pandemic Influenza A Virus H5N1
-
Soluna Announces Monthly Business Update
-
Lightspeed Announces Fiscal Fourth Quarter and Full Year 2025 Financial Results Conference Call
-
Snow Lake Updates on the Joint Venture with Global Uranium and Enrichment Limited on the Pine Ridge Uranium Project
-
Vertex Expands Chief Strategy Office to Advance E-Invoicing and Global Compliance Initiatives
-
Paul Dietrich and Fairfax Global Join Wedbush Securities Wealth Management
-
OneSpan to Announce First Quarter Financial Results on May 1, 2025
-
AtriCure Announces First Use of the AtriClip PRO-Mini® Device
-
ButcherBox Launches on Target.com
-
New Global Study Reveals Consumers Demand More Personalization in Marketing; 81% Ignore Irrelevant Messages, While Personalized Experiences Drive Loyalty and Sales
-
NV5 to Host First Quarter 2025 Conference Call on Thursday, May 1st at 4:30pm ET
-
Arcturus Therapeutics Receives U.S. FDA Fast Track Designation for the STARR® mRNA Vaccine Candidate ARCT-2304 for Pandemic Influenza A Virus H5N1
-
TG Therapeutics (TGTX) Announces Data Presentations for BRIUMVI
-
Palatin Technologies (PTN) to Present Positive Phase 2b Data for Melanocortin Agonist
-
Realbotix to Collaborate with Tix4 for Robotic Customer Service Agent
-
Palatin to Present Positive Phase 2b Data for Melanocortin Agonist in Diabetic Kidney Disease at the National Kidney Foundation Spring Meeting
-
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting
-
Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2025 Financial Results
-
Moderna to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
-
Hughes Announces Launch of Innovative Compact ESA, Further Expanding Global Connectivity Solutions
-
City of Hope Cancer Care Scottsdale Now Open at One Scottsdale Medical
-
An Open Letter Apologizing to JCPenney Fans For What We’re About To Do
-
Quantiphi Launches an Agent Thinking Workshop, Inspiring CHROs to Reimagine Employee Productivity with Google's Agentspace

